SCANDINAVIAN CHEMOTECH AB B revenue for the last year amounted to 2.80 M SEK, the most of which — 473.00 k SEK — came from its highest performing source at the moment, Tumor-specific Electroportation Technology, the year earlier bringing 49.00 k SEK. The greatest contribution to the revenue figure was made by Sweden — last year it brought SCANDINAVIAN CHEMOTECH AB B 473.00 k SEK, and the year before that — 49.00 k SEK.